Skip to main content

Market Overview

35 Stocks Moving In Monday's Mid-Day Session



  • American Electric Technologies, Inc (NASDAQ: AETI) shares jumped 135.2 percent to $1.74 after the company’s M&I Electric business announced a $14 million project with a leading Engineering, Procurement and Construction firm.
  • BIO-key International, Inc. (NASDAQ: BKYI) surged 34.5 percent to $3.00. BIO-key International disclosed that it has completed conversion of all outstanding preferred stock into common stock at a conversion price of $3.60 per share.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) shares rose 24.6 percent to $32.285 after the company reported updated interim Phase 1 clinical study results with DCC-2618 at the ASCO Annual Meeting.
  • Highpower International Inc (NASDAQ: HPJ) shares gained 15.9 percent to $3.332.
  • CSS Industries, Inc. (NYSE: CSS) climbed 11.5 percent to $18.035. DA Davidson upgraded CSS Industries from Neutral to Buy.
  • Denali Therapeutics Inc. (NASDAQ: DNLI) rose 10.8 percent to $20.88.
  • Immunomedics, Inc. (NASDAQ: IMMU) shares climbed 10.2 percent to $25.02. Clovis Oncology and Immunomedics reported a planned clinical collaboration to study combination therapies in metastatic triple-negative breast and urothelial cancers.
  • China Natural Resources, Inc. (NASDAQ: CHNR) rose 10.1 percent to $2.69.
  • Genomic Health, Inc. (NASDAQ: GHDX) shares climbed 10 percent to $43.6652 after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
  • Evolus, Inc. (NASDAQ: EOLS) climbed 7.4 percent to $29.31.
  • Petróleo Brasileiro S.A. - Petrobras (NYSE: PBRA) shares gained 7.1 percent to $9.165.
  • PFSweb, Inc. (NASDAQ: PFSW) gained 7.1 percent to $11.6776.
  • Digital Ally, Inc. (NASDAQ: DGLY) rose 4 percent to $2.75 after the company reported that the US Patent Office has denied Axon's request to invalidate a Digital Ally patent.

Check out these big penny stock gainers and losers


  • Nektar Therapeutics (NASDAQ: NKTR) shares dipped 41.3 percent to $52.9990. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
  • Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 37.4 percent to $7.015 after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
  • Daqo New Energy Corp. (NYSE: DQ) shares fell 21.2 percent to $41.56 after dropping 8.57 percent on Friday.
  • Vaxart, Inc. (NASDAQ: VXRT) dropped 17.9 percent to $4.304 as the company disclosed that its Phase 2 trial of teslexivir did not meet its primary endpoint.
  • Gevo, Inc. (NASDAQ: GEVO) dipped 16.1 percent to $4.03.
  • Blueprint Medicines Corporation (NASDAQ: BPMC) shares fell 14.8 percent to $72.00. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
  • Amtech Systems, Inc. (NASDAQ: ASYS) tumbled 14.8 percent to $8.45.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) fell 14.1 percent to $13.00 after dropping 14.07 percent on Friday.
  • PPDAI Group Inc. (NYSE: PPDF) fell 13.4 percent to $6.66.
  • Zymeworks Inc. (NYSE: ZYME) dropped 13 percent to $19.0132.
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) shares dipped 13 percent to $37.95 after the company presented Phase 1b data on G1T38 in combination with faslodex for treatment of breast cancer at the ASCO 2018.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) fell 12.3 percent to $4.20 after climbing 65.17 percent on Friday.
  • Moxian, Inc. (NASDAQ: MOXC) shares declined 10.8 percent to $1.91.
  • NovoCure Limited (NASDAQ: NVCR) dropped 10.3 percent to $28.675. Novocure will present INNOVATE-3 Phase 3 pivotal trial design in recurrent ovarian cancer at the ASCO Annual Meeting 2018.
  • ChemoCentryx, Inc. (NASDAQ: CCXI) fell 9.5 percent to $11.73.
  • Viking Therapeutics, Inc. (NASDAQ: VKTX) dropped 8.5 percent to $8.9191 after falling 2.40 percent on Friday. Viking Therapeutics shares more than doubled Thursday after a 145-percent jump in shares of Madrigal Pharmaceuticals, which announced data from a Phase 2 study of its non-alcoholic steatohepatitis pipeline candidate.
  • CRISPR Therapeutics AG (NASDAQ: CRSP) fell 7.9 percent to $61.850 after declining 2.58 percent on Friday.
  • Enphase Energy, Inc. (NASDAQ: ENPH) dropped 7.4 percent to $5.35. Enphase Energy named Eric Branderiz as Vice President and Chief Financial Officer.
  • Tactile Systems Technology, Inc. (NASDAQ: TCMD) slipped 6.6 percent to $47.10. BTIG Research downgraded Tactile Systems Technology from Buy to Neutral.
  • Colfax Corporation (NYSE: CFX) fell 6.1 percent to $28.89. Bank of America downgraded Colfax from Buy to Underperform.
  • The Trade Desk, Inc. (NASDAQ: TTD) dropped 5.9 percent to $81.505. Wells Fargo downgraded Trade Desk from Outperform to Market Perform.
  • Viper Energy Partners LP (NASDAQ: VNOM) fell 5.3 percent to $28.80. Stifel Nicolaus downgraded Viper Energy Partners from Buy to Hold.

Related Articles (AETI + ASYS)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at